X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (29045) 29045
Publication (3002) 3002
Book Review (629) 629
Newspaper Article (416) 416
Book Chapter (223) 223
Newsletter (158) 158
Conference Proceeding (98) 98
Magazine Article (63) 63
Book / eBook (25) 25
Dissertation (20) 20
Transcript (12) 12
Trade Publication Article (11) 11
Data Set (8) 8
Reference (8) 8
Web Resource (3) 3
Government Document (1) 1
Paper (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15841) 15841
animals (13597) 13597
male (13027) 13027
dopamine (12375) 12375
index medicus (11078) 11078
neurosciences (9614) 9614
pharmacology & pharmacy (8292) 8292
rats (7290) 7290
female (7207) 7207
psychiatry (5446) 5446
dopamine - metabolism (4393) 4393
parkinson's disease (4329) 4329
clinical neurology (3972) 3972
adult (3963) 3963
middle aged (3913) 3913
mice (3373) 3373
schizophrenia (3259) 3259
dose-response relationship, drug (3208) 3208
parkinson disease - drug therapy (2873) 2873
brain (2808) 2808
rats, sprague-dawley (2705) 2705
aged (2695) 2695
antipsychotic agents - therapeutic use (2508) 2508
disease models, animal (2250) 2250
parkinsons-disease (2220) 2220
serotonin (2110) 2110
analysis (2092) 2092
schizophrenia - drug therapy (2066) 2066
neurons (2045) 2045
neurology (1992) 1992
antiparkinson agents - therapeutic use (1977) 1977
treatment outcome (1958) 1958
article (1893) 1893
dopamine agonists - therapeutic use (1889) 1889
dopamine agents - therapeutic use (1882) 1882
time factors (1807) 1807
motor activity - drug effects (1804) 1804
brain - metabolism (1799) 1799
dopamine receptors (1765) 1765
brain - drug effects (1754) 1754
double-blind (1708) 1708
levodopa - therapeutic use (1691) 1691
research (1681) 1681
rodents (1629) 1629
antipsychotic agents - pharmacology (1577) 1577
rats, wistar (1576) 1576
nucleus-accumbens (1531) 1531
behavior, animal - drug effects (1507) 1507
phenols (1478) 1478
drug therapy (1442) 1442
cocaine (1438) 1438
receptors (1385) 1385
corpus striatum - metabolism (1368) 1368
corpus striatum - drug effects (1340) 1340
dopamine - physiology (1321) 1321
care and treatment (1299) 1299
biomedicine (1295) 1295
prefrontal cortex (1285) 1285
drugs (1281) 1281
rat (1247) 1247
biochemistry & molecular biology (1227) 1227
parkinsons disease (1222) 1222
health aspects (1205) 1205
oxidative stress (1199) 1199
levodopa (1192) 1192
pharmacology (1184) 1184
movement disorders (1162) 1162
in-vivo (1154) 1154
pharmacology/toxicology (1144) 1144
antipsychotic agents - adverse effects (1123) 1123
basal ganglia (1116) 1116
haloperidol (1115) 1115
neurons - drug effects (1106) 1106
parkinson disease - physiopathology (1092) 1092
striatum (1087) 1087
behavioral sciences (1085) 1085
neurodegenerative diseases (1084) 1084
double-blind method (1068) 1068
receptors, dopamine - drug effects (1060) 1060
mice, inbred c57bl (1056) 1056
adolescent (1047) 1047
physiological aspects (1031) 1031
medicine (1029) 1029
depression (1026) 1026
nervous system (1019) 1019
serotonin - metabolism (1012) 1012
ventral tegmental area (988) 988
dopamine - therapeutic use (981) 981
amphetamine (975) 975
analysis of variance (975) 975
mental disorders (957) 957
drug interactions (950) 950
drug therapy, combination (940) 940
neurons - metabolism (939) 939
substantia-nigra (936) 936
reward (926) 926
dopamine agonists - pharmacology (925) 925
norepinephrine (925) 925
neuroprotection (914) 914
studies (909) 909
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (19) 19
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Periodical Stacks (1) 1
Online Resources - Online (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (28801) 28801
German (232) 232
French (208) 208
Spanish (137) 137
Japanese (116) 116
Russian (105) 105
Polish (47) 47
Italian (38) 38
Hungarian (33) 33
Dutch (27) 27
Chinese (18) 18
Danish (17) 17
Portuguese (17) 17
Swedish (12) 12
Finnish (10) 10
Norwegian (7) 7
Romanian (7) 7
Turkish (7) 7
Bulgarian (6) 6
Hebrew (3) 3
Ukrainian (3) 3
Croatian (2) 2
Czech (2) 2
Lithuanian (2) 2
Afrikaans (1) 1
Arabic (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Psychiatry and Clinical Neurosciences, ISSN 1323-1316, 06/2015, Volume 69, Issue 6, pp. 321 - 334
Tardive dyskinesia is a serious, disabling and potentially permanent, neurological hyperkinetic movement disorder that occurs after months or years of taking... 
first‐generation agents | schizophrenia | management | second‐generation agents | tardive dyskinesia | second-generation agents | first-generation agents | VITAMIN-E TREATMENT | NEUROTROPHIC FACTOR LEVELS | SCHIZOPHRENIC-PATIENTS | PSYCHIATRY | GINKGO-BILOBA | CHAIN AMINO-ACIDS | NEUROSCIENCES | ATYPICAL ANTIPSYCHOTICS | CLINICAL NEUROLOGY | HYPERKINETIC MOVEMENT-DISORDERS | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | ESSENTIAL FATTY-ACIDS | Stilbenes - therapeutic use | Antipsychotic Agents - adverse effects | Humans | Propranolol - therapeutic use | Leucine - therapeutic use | Dopamine Agents - therapeutic use | Amantadine - therapeutic use | Piracetam - therapeutic use | Pyridoxine - therapeutic use | Clonazepam - therapeutic use | Drugs, Chinese Herbal - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Adrenergic Uptake Inhibitors - therapeutic use | Anticonvulsants - therapeutic use | Nootropic Agents - therapeutic use | Isoleucine - therapeutic use | Vitamins - therapeutic use | Ginkgo biloba | alpha-Tocopherol - therapeutic use | Antioxidants - therapeutic use | Movement Disorders - etiology | Piracetam - analogs & derivatives | Melatonin - therapeutic use | Fatty Acids, Omega-3 - therapeutic use | Valine - therapeutic use | Isoxazoles - therapeutic use | Plant Extracts - therapeutic use | Movement Disorders - drug therapy | Tetrabenazine - therapeutic use | Schizophrenia | Movement disorders | Tardive dyskinesia | Medical research
Journal Article
Journal Article
Critical Care Medicine, ISSN 0090-3493, 03/2012, Volume 40, Issue 3, pp. 725 - 730
OBJECTIVES:There has long-been controversy about the possible superiority of norepinephrine compared to dopamine in the treatment of shock. The objective was... 
adverse effects | mortality | adrenergic agents | vasopressor | outcome | MANAGEMENT | SEPSIS | CRITICAL CARE MEDICINE | Adrenergic alpha-Agonists - therapeutic use | Dopamine - therapeutic use | Norepinephrine - therapeutic use | Dopamine Agents - therapeutic use | Humans | Shock, Septic - drug therapy
Journal Article
Annals of Neurology, ISSN 0364-5134, 07/2010, Volume 68, Issue 1, pp. 18 - 27